General Information of This Metabolic Reaction (MR) (ID:
MR006675) |
Formula |
|
Reactant |
Doxorubicin |
Product |
Doxorubicinol |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
NADPH-dependent carbonyl reductase 1 (CBR1)
|
DME Info
|
NADPH-dependent carbonyl reductase 3 (CBR3)
|
DME Info
|
Aldo-keto reductase 1C3 (AKR1C3)
|
DME Info
|
Aldo-keto reductase 1A1 (AKR1A1)
|
DME Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients
|
2 |
PharmGKB:Doxorubicin
|
3 |
Pharmacogenomics knowledge for personalized medicine Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.